Description: UN: Understanding the drug treaties: WHO Cannabis / Cannabidiol critical review and the recommendations:
What’s next for global cannabis
The seminar will cover:
- Drug treaty system: why it matters
- The WHO cannabis/cannabidiol review: outcomes
- International Cannabis Markets: Where do we stand in the work and how do we compete in the global market
Amy Case King Bio– Amy Case King is the founder of Delta 9 Mexico, a company dedicated to the advancement of cannabis policies and scientific research in Mexico. She has spent a number of years as a patient advocate and policy advisor to the passage of medical cannabis laws in a number of US States. She is a certified Holistic cannabis practitioner from the Holistic Cannabis Academy. https://holisticcannabisacademy.com/practitioner-directory/amy-king/
Ms. King is a member of the US Pain Foundation, an organization that serves to empower, educates and advocate for people living with chronic conditions that cause pain.
She serves as a board member for We Are Rare, where she works closely with leading medical physicians to investigate, support and educate about rare brain disorders, such as Schizencephaly, Plagiocephaly, Microcephaly /Hydrocephalus/macrocephalic disorders, Lissencephaly, and a traumatic brain injury / in utero stroke before birth.
As a patient advocate and a person living with chronic pain and disease herself, Amy has provided direct and written testimony to the WHO for their expert investigation into Cannabis Sativa. She has also provided intervention to the United Nations Office of Drugs and Crime (UNODC)
She is an avid supporter for the acceptance of industrial cannabis to be used in the daily lives of people around the world for food, clothing, and shelter. She also hopes to see Cannabis Sativa as a botanical monograph under the WHO as a Traditional, complementary and integrative medicine.
Amy Case King